Tumour Marker CEA (Carcino-embryonic Antigen)

serum (possibly also EDTA plasma, heparin plasma) 1 ml

CLA

1 day

• Values increase due to tumours of the gastrointestinal tract and the mammary glands, but also due to inflammatory processes.
• Therapy monitoring: In case of previous positive findings after surgical and/or chemotherapy, concentration should be within normal range. Relapse monitoring (every 6 months).